Study Design
population-based cross sectional survey.
Objective
To compare the prevalence of illicit drug use among US adults with chronic low back pain (cLBP) and without.
Summary of Background Data
While addictive medications, such as opioids and benzodiazepines, are frequently prescribed to patients with cLBP, little is known about illicit drug use among Americans with cLBP.
Methods
We used data from the back pain survey, administered to a representative sample of US adults aged 20-69 (N = 5103) during the 2009-2010 cycle of the National Health and Nutrition Examination Survey (NHANES). Participants with pain in the area between the lower posterior margin of the ribcage and the horizontal gluteal fold for at least 3 months were classified as having cLBP (N = 700). The drug use questionnaire was self-administered in a private setting, and included data on lifetime and current use of marijuana or hashish, cocaine, heroin, and methamphetamine. Chi-square tests, one way ANOVA and logistic regression, adjusted for age, gender, race and level of education, were used for comparisons.
Results
46.5% of US adults with cLBP used marijuana vs 42% of those without cLBP (aOR 1.36, 95% CI 1.06-1.74). 22% vs 14% used cocaine (aOR 1.80, 95% CI 1.45-2.24), 9% vs 5% used methamphetamine (aOR 2.03, 95% CI 1.30-3.16), and 5% vs 2% used heroin (aOR 2.43, 95% CI 1.44-4.11). Subjects with cLBP who reported lifetime illicit drug use were more likely to have an active prescription for opioid analgesics than those without illicit drug use history: 22.5% vs 15.3%, p = 0.018.
Conclusions
cLBP in community-based US adults was associated with higher odds of using marijuana, cocaine, heroin, and methamphetamine. Prescription opioid analgesic use was more common in cLBP sufferers with a history of illicit drug use.